
Merger1 Aug 2026, 02:01 pm
Orchid Pharma Approves 4.45 Cr Share Allotment in Amalgamation
AI Summary
Orchid Pharma Ltd's Board of Directors has approved the issuance and allotment of 4,45,86,052 fully paid-up equity shares of Rs. 10 each to eligible shareholders of Dhanuka Laboratories Limited. This allotment is pursuant to a scheme of Amalgamation, with the record date set as July 23, 2026. The newly issued shares will be listed and traded on BSE and NSE, ranking pari-passu with existing equity shares. Following the allotment and cancellation of cross-holdings, the company's paid-up share capital has increased to Rs. 59,88,52,000, divided into 5,98,85,200 equity shares.
Key Highlights
- Board approved allotment of 4.45 Cr equity shares.
- Allotment is part of a scheme of Amalgamation with Dhanuka Laboratories.
- New shares to be listed on BSE and NSE, ranking pari-passu.
- Paid-up capital increased to Rs. 59.88 Cr post-allotment.
Price Impact
More from ORCHIDPHAR